Retrieve available abstracts of 17 articles: HTML format
Single Articles
March 2025
CHUBYKINA U, Vasiluev P, Ivanova O, Ezhov M, et al The Mysterious Masks of Hypercholesterolemia: A Unique Clinical Case.
Circulation. 2025;151:799-803. PubMed
November 2024
LIU J, Bellows BK, Jacobs DR Jr, Woo JG, et al Low-Density Lipoprotein Cholesterol Level Distributions Across Different Ages:
Implications for Screening Children for Severe and Familial Hypercholesterolemia.
Circulation. 2024;150:1741-1744. PubMed
August 2024
DAMASE TR, Sukhovershin R, Godin B, Nasir K, et al Established and Emerging Nucleic Acid Therapies for Familial
Hypercholesterolemia.
Circulation. 2024;150:724-735. PubMedAbstract available
April 2024
TAMARGO IA, Baek KI, Xu C, Kang DW, et al HEG1 Protects Against Atherosclerosis by Regulating Stable Flow-Induced KLF2/4
Expression in Endothelial Cells.
Circulation. 2024;149:1183-1201. PubMedAbstract available
February 2024
STONE NJ, Blum C If Action is Delayed, Is Survival Denied? Management of Severe
Hypercholesterolemia Is Important and Urgent.
Circulation. 2024;149:427-429. PubMed
January 2024
SANTOS RD, Cuchel M LDL-C-Lowering Therapies for Adults and Children With Homozygous Familial
Hypercholesterolemia: Challenges and Successes.
Circulation. 2024;149:363-366. PubMed
November 2023
YALCINKAYA M, Liu W, Thomas LA, Olszewska M, et al BRCC3-Mediated NLRP3 Deubiquitylation Promotes Inflammasome Activation and
Atherosclerosis in Tet2 Clonal Hematopoiesis.
Circulation. 2023;148:1764-1777. PubMedAbstract available
MILES J, Scotti A, Castagna F, Kuno T, et al Long-Term Mortality in Patients With Severe Hypercholesterolemia Phenotype From a
Racial and Ethnically Diverse US Cohort.
Circulation. 2023 Nov 16. doi: 10.1161/CIRCULATIONAHA.123.064566. PubMedAbstract available
October 2023
WIEGMAN A, Greber-Platzer S, Ali S, Doortje Reijman M, et al Evinacumab for Pediatric Patients With Homozygous Familial Hypercholesterolemia.
Circulation. 2023 Oct 20. doi: 10.1161/CIRCULATIONAHA.123.065529. PubMedAbstract available
RAAL F, Durst R, Bi R, Talloczy Z, et al Efficacy, Safety, and Tolerability of Inclisiran in Patients With Homozygous
Familial Hypercholesterolemia: Results From the ORION-5 Randomized Clinical
Trial.
Circulation. 2023 Oct 18. doi: 10.1161/CIRCULATIONAHA.122.063460. PubMedAbstract available
September 2023
ALDANA-BITAR J, Karlsberg RP, Budoff MJ Letter by Aldana-Bitar et al Regarding Article, "Alirocumab and Coronary
Atherosclerosis in Asymptomatic Patients With Familial Hypercholesterolemia: The
ARCHITECT Study".
Circulation. 2023;148:1057. PubMed
PEREZ DE ISLA L, Saltijeral Cerezo A, Mata P Response by Perez de Isla et al to Letter Regarding Article, "Alirocumab and
Coronary Atherosclerosis in Asymptomatic Patients With Familial
Hypercholesterolemia: The ARCHITECT Study".
Circulation. 2023;148:1059-1060. PubMed
LONG X, Jiang M Letter by Long and Jiang Regarding Article, "Alirocumab and Coronary
Atherosclerosis in Asymptomatic Patients With Familial Hypercholesterolemia: The
ARCHITECT Study".
Circulation. 2023;148:1058. PubMed
July 2023
JOHNS DG, Campeau LC, Banka P, Bautmans A, et al Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low
Density Lipoprotein Receptor.
Circulation. 2023;148:144-158. PubMedAbstract available
May 2023
ZHANG Y, Dron JS, Bellows BK, Khera AV, et al Association of Severe Hypercholesterolemia and Familial Hypercholesterolemia
Genotype With Risk of Coronary Heart Disease.
Circulation. 2023;147:1556-1559. PubMed
April 2023
PEREZ DE ISLA L, Diaz-Diaz JL, Romero MJ, Muniz-Grijalvo O, et al Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients with Familial
Hypercholesterolemia: The ARCHITECT Study.
Circulation. 2023 Apr 3. doi: 10.1161/CIRCULATIONAHA.122.062557. PubMedAbstract available
February 2023
PAN C, Herrero-Fernandez B, Borja Almarcha C, Gomez Bris R, et al Time-Restricted Feeding Enhances Early Atherosclerosis in Hypercholesterolemic
Mice.
Circulation. 2023;147:774-777. PubMed